Evidence map›Paper›PMID 32363592›Full record

Trial reportAlcoholism, clinical and experimental research2020

Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.

Robert Miranda, Stephanie S O'Malley, Hayley Treloar Padovano, Ran Wu, Daniel E Falk, Megan L Ryan, Joanne B Fertig, Thomas H Chun, Srinivas B Muvvala, Raye Z Litten

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Alcoholism, clinical and experimental research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Alcohol use disorder severity moderates clinical response to varenicline.Alcoholism, clinical and experimental research · 2021
    Trial
  7. Trial
  8. Article
  9. Review
  10. Who is alcohol cue-reactive? A machine learning approach.Alcohol and alcoholism (Oxford, Oxfordshire) · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Robert MirandaFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.ORCID 0000-0001-6418-6148
Stephanie S O'MalleyFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.ORCID 0000-0002-1976-2369
Hayley Treloar PadovanoFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.ORCID 0000-0001-5347-4291
Ran WuFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.
Daniel E FalkFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.ORCID 0000-0002-3753-2786
Megan L RyanFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.
Joanne B FertigFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.
Thomas H ChunFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.
Srinivas B MuvvalaFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.ORCID 0000-0003-2766-2074
Raye Z LittenFrom the, Department of Psychiatry and Human Behavior, (RMJ, SSO, HTP, RW, DEF, MLR, JBF, THC, SBM, RZL), Brown University, Providence, Rhode Island, USA.ORCID 0000-0001-7497-0809
Brown University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translational Technologies CoreP50AA012870 · NIAAA · YALE UNIVERSITY · PI John H. Krystal · 2001 to 2026
$43.7M
1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent SmokersR01AA020388 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2012 to 2015
$2.1M
Mentored Patient-Oriented Research on Adolescent Alcohol Misuse and TreatmentK24AA026326 · NIAAA · BROWN UNIVERSITY · PI ROBERT MIRANDA · 2018 to 2026
$1.7M
Novel Approaches to Understanding How Alcohol Pathology Develops in AdolescentsK23AA024808 · NIAAA · BROWN UNIVERSITY · PI TRELOAR PADOVANO, HAYLEY · 2017 to 2021
$973k
2/2-Multisite Study: Varenicline for Alcohol Dependent SmokersR01AA020389 · NIAAA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ZWEBEN, ALLEN · 2012 to 2015
$950k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS HHSN275201500007INIAAA NIH HHS K23 AA024808NIAAA NIH HHS K24 AA026326NIAAA NIH HHS P50 AA012870NIAAA NIH HHS R01 AA020388NIAAA NIH HHS R01 AA020389NICHD NIH HHS HHSN275201500007I
6 · The paper itself

Abstract

backgroundThe alcohol cue reactivity paradigm is increasingly used to screen medications for the treatment of alcohol use disorder (AUD) and other substance use disorders. Yet, its prospective association with craving and naturalistic drinking outcomes in clinical trials remains unknown. This study embedded repeated human laboratory assessments of alcohol cue reactivity within the context of a randomized controlled trial to examine the effects of varenicline tartrate (Chantix DESIGN AND

methodsThis double-blind, randomized, 2-site study compared the effects of varenicline (up to 2 mg/d) and placebo on responses to in vivo alcohol cue and affective picture cue exposure in the human laboratory. Forty-seven volunteers (18 females, 29 males), ages 23 to 67 years (M = 43.7, SD = 11.5), were recruited from the community via advertisements to participate in a clinical trial designed to study the effects of varenicline on alcohol use. Participants were randomized to either varenicline or placebo for 6 weeks.

resultsVarenicline did not attenuate cue-induced alcohol craving relative to placebo, but craving captured during the cue reactivity paradigm significantly predicted subsequent alcohol use in real-world settings during the clinical trial. Higher craving predicted heavier alcohol use.

conclusionsOur results are among the first to show alcohol cue-induced craving captured during a human laboratory paradigm predicts drinking outcomes in the context of a clinical trial.

Indexed as

CravingCuesAdultAgedAlcohol DrinkingAlcoholismDouble-Blind MethodFemaleHumansMaleMiddle AgedNicotinic AgonistsTreatment OutcomeVareniclineYoung AdultNicotinic AgonistsVareniclineAlcoholCue ReactivityHuman LaboratoryVarenicline

Identifiers

PMID32363592
PMCPMC7572549
OpenAlexW3022767945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.